Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

676 recalls · Class II, newest first

Class II · Moderate risk

Merck Emend

Presence of particulate matter: potential presence of metal particulates in the product.

Ongoing Particulate / foreign matter Merck Sharp & Dohme LLC NDC 0006-3066-03 D-0241-2026
Class II · Moderate risk

Ciclopirox Shampoo

Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Ongoing Impurity / degradation Sun Pharma /Taro NDC 51672-1351-08 D-0240-2026
Class II · Moderate risk

Ondansetron ODT Tablets

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Ongoing Packaging defect Preferred Pharmaceuticals, Inc. NDC 68788-8666-01 D-0239-2026
Class II · Moderate risk

Ganirelix Acetate Injection

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Ongoing Impurity / degradation Lupin Pharmaceuticals Inc. NDC 70748-274-01 D-0220-2026
Class II · Moderate risk

OraVerse

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 0362-0101-10 D-0234-2026
Class II · Moderate risk

Cook-Walte

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 0362-0753-05 D-0233-2026
Class II · Moderate risk

darby dental supply

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66467-9760-5 D-0231-2026
Class II · Moderate risk

3% Polocaine DENTAL

Defective container: cracked/broken cartridges

Ongoing Packaging defect Novocol Pharmaceutical of Canada, Inc. NDC 66312-441-16 D-0230-2026

Recalls by year